Assessing the impact of triiodothyronine treatment on the lung microbiome of mice with pulmonary fibrosis
The administration of T<sub>3</sub> demonstrated a favorable impact on the lung microbiota of mice afflicted with PF, thereby partially substantiating the potential role of T<sub>3</sub> as a therapeutic agent in the management of PF.
Authors
- Guoying Yu (ORCID: https://orcid.org/0000-0002-4124-1359)
- Qiwen Wang (ORCID: https://orcid.org/0000-0002-4255-3960)
- Xiaoshu Guo (ORCID: https://orcid.org/0000-0002-7046-1641)
- Kai Xu (ORCID: https://orcid.org/0000-0001-8763-8100)
- Zongyuan Han
Institutions
- Changzhi Medical College (CN)
- Institute of Molecular and Cell Biology (RU)
- Henan Normal University (CN)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1186/s12890-024-03214-3
- Citations
- 1
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.42